Saket Jhajharia

About

Saket has over eight years of research and investment experience and holds a Ph.D. in Immunology & Microbiology. He has worked on projects related to infectious diseases, cancer, ophthalmology, and autoimmune diseases. He also holds a patent for a Hepatitis B antibody drug. Along with his early curiosity in investing in public markets and writing for The Motley Fool, Saket was part of a venture capital team at a family office for the past two years, where he invested in the life science vertical. Saket's interest lies in agrifoodtech, sustainability, and creating a healthy ecosystem for future generations.

Source (opens in a new tab)